Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
UCHL1 Monoclonal Antibody (OTI2B5), TrueMAB™, OriGene

Mouse Monoclonal Antibody
Supplier: OriGene TA504289S


Description
UCHL1 Monoclonal antibody specifically detects UCHL1 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry (Paraffin), Western BlotSpecifications
UCHL1 | |
Monoclonal | |
1 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
P07992 | |
Mouse | |
Affinity chromatography | |
RUO | |
2067 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG1 |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
OTI2B5 | |
Unconjugated | |
ERCC1 | |
AW822034; C88048; epididymis luminal protein 117; epididymis secretory protein Li 53; gad; gracile axonal dystrophy; HEL-117; HEL-S-53; MGC133697 protein; NDGOA; neuron cytoplasmic protein 9.5; OTTHUMP00000218137; OTTHUMP00000218139; OTTHUMP00000218140; OTTHUMP00000218141; PARK5; PGP 9.5; PGP9.5; PGP95; protein gene product 9.5; R75593; ubiquitin carboxyl-terminal esterase; ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase); ubiquitin carboxyl-terminal hydrolase isozyme L1; ubiquitin carboxyl-terminal hydrolase L1; ubiquitin carboxy-terminal hydrolase L1; ubiquitin C-terminal hydrolase; ubiquitin C-terminal hydrolase 1; ubiquitin C-terminal hydrolase L1; ubiquitin thioesterase L1; ubiquitin thiolesterase; ubiquitin thiolesterase L1; UCHL; UCHL1; UCH-L1; UCHL-1 | |
Full length human recombinant protein of human ERCC1 produced in HEK293T cell. | |
30 μL | |
Primary | |
Human | |
Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction